Now overall between December 2021 and February 2022 thorough seroprevalence, in other words, the presence of antibodies to the virus in the bloodstream increased across all US age groups from 34% in December 2021 to 58% in February 2022.
Dr. Kristie Clarke:
Again, this study was only looking at the presence of antibodies from prior infection and did not detect antibodies from prior vaccination, whether it be primary series or boosting. The largest increases were observed, as I mentioned, among children and teens, those 17 and younger of whom by February 2022, roughly 75% or 3 in 4 had developed antibodies due to prior infection.